Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
James William Garcelon Insider Profile
4 Followers
James William Garcelon, Ten Percent Owner at Canntab Therapeutics Limited, holds 7.45M shares in Canntab Therapeutics Limited (Ticker: TSE:PILL), holds 19.30M shares in Western Uranium (Ticker: TSE:WUC), holds 2.00M shares in King Global Ventures (Ticker: TSE:KING). Most recently, James William Garcelon Bought ― shares of Canntab Therapeutics Limited on Jun 25, 2015 for an estimated value of 19.20K.
James William Garcelon has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that James William Garcelon holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by James William Garcelon
James William Garcelon's Trading History
Canntab Therapeutics Limited
Jun 25, 2015
Ten Percent Owner
Informative Buy
19.20K
C$74.48K
Western Uranium
Oct 24, 2013
Director
Informative Buy
14.53K
C$40.93M
King Global Ventures
Oct 16, 2013
Director
Informative Buy
10.00K
C$826.00K
List of latest transactions for each holding click on a transaction to see James William Garcelon's performance on stock
You May Also Like
James William Garcelon insider profile FAQ
What is the percentage of profitable transactions made by James William Garcelon?
The percentage of profitable transactions made by James William Garcelon is ―.
What is the average return per transaction made by James William Garcelon?
The average return per transaction made by James William Garcelon is ―.
What stocks does James William Garcelon hold?
James William Garcelon holds: TSE:PILL, TSE:WUC, TSE:KING stocks.
What was James William Garcelon’s latest transaction?
James William Garcelon latest transaction was an Informative Buy of C$19.20K.
What was James William Garcelon's most profitable transaction?
James William Garcelon’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is James William Garcelon's role in Canntab Therapeutics Limited?
James William Garcelon's role in Canntab Therapeutics Limited is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.